The Medicines Company (MDCO_old)

NASDAQ
84.90
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    84.88 - 84.98
  • 52 wk Range:
    0.00 - 0.00

MDCO_old Overview

Prev. Close
84.96
Day's Range
84.88-84.98
Revenue
-
Open
84.96
52 wk Range
0-0
EPS
-3.13
Volume
0
Market Cap
6.79B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,501,256
P/E Ratio
-
Beta
1.11
1-Year Change
0%
Shares Outstanding
79,948,329
Next Earnings Date
-
What is your sentiment on The Medicines?
or
Market is currently closed. Voting is open during market hours.

The Medicines Company News

The Medicines Company Analysis

The Medicines Company Company Profile

The Medicines Company Company Profile

Employees
62

The Medicines Company, a biopharmaceutical company, focuses on developing therapeutics for the treatment of therosclerotic cardiovascular disease. The company is developing Inclisiran, an investigational RNA interference therapeutic that inhibits production of proprotein convertase subtilisin/kexin type 9, which controls LDL-cholesterol levels. It has collaboration agreement with Alnylam Pharmaceuticals, Inc. The Medicines Company was founded in 1996 and is headquartered in Parsippany, New Jersey. As of January 3, 2020, The Medicines Company operates as a subsidiary of Novartis AG.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary